Metraipolis › archive › dc_3f09a7bb34cd
Obinutuzumab treatment for antineutrophil cytoplasmic antibody-associated vasculitis — Europe PMC PMID:42212146
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42212146
- DOI
- 10.3389/fimmu.2026.1787558
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T09:44:50.868Z
- SHA-256 of the archived text
72c74a6eca63271b5cba6f7c39c57a61064ea614e45c5204423f7a5f95e6df49- Stable URL of this page
https://metraipolis.com/documento/dc_3f09a7bb34cd
How to cite
Obinutuzumab treatment for antineutrophil cytoplasmic antibody-associated vasculitis — Europe PMC PMID:42212146 — Europe PMC (en), https://europepmc.org/article/MED/42212146 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3f09a7bb34cd (Metraipolis archive dc_3f09a7bb34cd, sha256 72c74a6eca63271b5cba6f7c39c57a61064ea614e45c5204423f7a5f95e6df49)
BibTeX
@misc{dc3f09a7bb34cd,
title = {Obinutuzumab treatment for antineutrophil cytoplasmic antibody-associated vasculitis — Europe PMC PMID:42212146},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42212146},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3f09a7bb34cd; sha256 72c74a6eca63271b5cba6f7c39c57a61064ea614e45c5204423f7a5f95e6df49},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42212146. Agents can read the archived copy with the MCP tool read_document.